University Of California Los Angeles

The California Institute for Regenerative Medicine has awarded a $4.6 million grant for a phase 1 clinical trial of a new modified blood-forming stem cell immunotherapy targeting sarcomas and other tumors that produce the NY-ESO-1 protein.

Experts provided their take-home messages from Cardiovascular Research Technologies in 2019.

Postmenopausal women reduced their breast cancer reduced their mortality risk by adopting a low-fat diet that included increased consumption of vegetables, fruits and grains, according to results from a randomized Women’s Health Initiative clinical trial scheduled for presentation at ASCO Annual Meeting.

NEW ORLEANS — Interim data from the REPAIR study show significant improvement in right ventricular function, including reversal of RV remodeling and reduced pulmonary vascular resistance, at 26 weeks after treatment with macitentan in patients with pulmonary artery hypertension.

PHILADELPHIA — While obstructive sleep apnea often goes undiagnosed, known risk factors, symptoms and assessment tools can help primary care physicians identify the disease, according to a presentation at the ACP Internal Medicine Meeting.

Administering pembrolizumab to patients with glioblastoma before surgery appeared to significantly improve OS compared with administration after surgery, according to results of a randomized, multi-institution trial published in Nature Medicine.

Antoni Ribas, MD, PhD, has been elected president-elect of American Association for Cancer Research for the 2019-2020 term.

Researchers have launched a research consortium that they hope will identify efficient methods to incorporate patient-reported outcomes into clinical trials of experimental cancer treatments.

Researchers found a consistent association between eating nuts, particularly walnuts, and fewer and less frequent depressive symptoms in a representative sample of the U.S. population over a 10-year period.

Whites were more likely to receive prescriptions for opioids and were more likely to die of an overdose, according to two new studies published in JAMA Internal Medicine. A third study indicated that overall opioid prescribing was decreasing in the majority of counties in the United States.